Mahesh Eswarappa, John Manns Manohar, Konana Gurudev Channabasappa, Parampalli Rakesh Madhyastha, Bande Sujeeth Reddy, Suryadevara Sarita
Department of Nephrology, M. S. Ramaiah Memorial Hospital, Bengaluru, Karnataka, India.
Saudi J Kidney Dis Transpl. 2017 Sep-Oct;28(5):1106-1111. doi: 10.4103/1319-2442.215132.
Human immunodeficiency virus (HIV) infection has posed as a major global health epidemic for almost three decades. With the advent of highly active antiretroviral therapy in 1996 and the application of prophylaxis and management of opportunistic infections, acquired immunodeficiency syndrome mortality has decreased markedly. The most aggressive HIV-related renal disease is end-stage renal disease due to HIV-associated nephropathy. Presence of HIV infection used to be viewed as a contraindication to renal transplantation for multiple reasons; concerns for exacerbation of an already immunocompromised state by administration of additional immunosuppressants; the use of a limited supply of donor organs with unknown long-term outcomes. Multiple studies have reported promising outcomes at three to five years after kidney transplantations in patients treated with highly active antiretroviral therapy, and HIV is no longer a contraindication for renal transplant. Hence, we present eight HIV-positive patients who received live-related renal transplantation at our center and their follow-up.
近三十年来,人类免疫缺陷病毒(HIV)感染已成为全球主要的健康流行病。随着1996年高效抗逆转录病毒疗法的出现以及机会性感染预防和管理的应用,获得性免疫缺陷综合征的死亡率显著下降。最具侵袭性的HIV相关肾病是由HIV相关性肾病导致的终末期肾病。由于多种原因,HIV感染曾被视为肾移植的禁忌证;担心额外使用免疫抑制剂会加重本已免疫受损的状态;担心使用有限的供体器官且长期预后不明。多项研究报告称,接受高效抗逆转录病毒疗法治疗的患者在肾移植后三到五年取得了令人鼓舞的结果,HIV不再是肾移植的禁忌证。因此,我们介绍了在我们中心接受活体亲属肾移植的八名HIV阳性患者及其随访情况。